Bisphosphonates in Langerhans Cell Histiocytosis: An International Retrospective Case Series

BACKGROUND: Bone is the most common organ of involvement in patients with Langerhans cell histiocytosis (LCH), which is often painful and associated with significant morbidity from pathological fractures. Current first-line treatments include chemotherapy and steroids that are effective but often as...

Descripción completa

Detalles Bibliográficos
Autores principales: Chellapandian, Deepak, Makras, Polyzois, Kaltsas, Gregory, van den Bos, Cor, Naccache, Lamia, Rampal, Raajit, Carret, Anne-Sophie, Weitzman, Sheila, Egeler, R. Maarten, Abla, Oussama
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Università Cattolica del Sacro Cuore 2016
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4928520/
https://www.ncbi.nlm.nih.gov/pubmed/27413525
http://dx.doi.org/10.4084/MJHID.2016.033

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4928520/
https://www.ncbi.nlm.nih.gov/pubmed/27413525
http://dx.doi.org/10.4084/MJHID.2016.033

Ejemplares similares